566 studies found for:    HAART
Show Display Options
Rank Status Study
21 Terminated
Has Results
A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Raltegravir
22 Completed A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone
Condition: HIV Infections
Interventions: Drug: Indinavir sulfate;   Drug: Lamivudine;   Drug: Stavudine;   Drug: Zidovudine;   Drug: Didanosine;   Drug: Aldesleukin
23 Completed Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: HAART containing nevirapine
24 Unknown  Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa
Condition: HIV
Intervention: Drug: Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC
25 Unknown  Heart Function in HIV-Negative Children Exposed to HIV and HAART
Condition: HIV Infections
Intervention:
26 Completed Effect of DHA on Lipid and Carbohydrate Metabolism Alterations and Body Fat Distribution in HIV Patients Under HAART.
Conditions: HIV-associated Hypertriglyceridemia;   HIV-associated Hypercholesterolemia;   HIV-associated Inflammatory State
Intervention: Drug: Docosahexaenoic acid (DHA) administration to modulate Triglycerides in HIV patients under HAART
27 Completed Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART
Condition: HIV
Intervention:
28 Withdrawn Effects of Mixed Exercise Regime and L-Carnitine Supplementation in HIV Patients on HAART
Conditions: HIV Infections;   Hyperlipidemia;   Exercise
Intervention: Dietary Supplement: l-carnitine
29 Completed IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites
Conditions: IRIS;   HIV
Intervention:
30 Active, not recruiting New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients
Condition: HIV Infections
Intervention: Drug: 2 NRTI + 1 PI/r + Maraviroc + Raltegravir
31 Completed HIV Treatment and CVD Events
Conditions: HIV Infection;   Cardiovascular Disease;   Infection, Human Immunodeficiency Virus;   Acute Myocardial Infarction
Intervention: Drug: HAART Treatment
32 Not yet recruiting A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)
Conditions: Human Immunodeficiency Virus (HIV);   HIV Associated Neurocognitive Disorders (HAND)
Intervention: Drug: Maraviroc
33 Terminated Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults
Condition: HIV Infections
Intervention: Device: pillbox, wristwatch
34 Unknown  Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Genetic: GX-12;   Drug: HAART
35 Completed An Intervention to Improve Antenatal Access to CD4 Testing and HAART in Botswana
Conditions: HIV Infection;   Pregnancy
Intervention: Other: Tokafatso programmatic intervention
36 Completed HAART Model 300 Annuloplasty Ring
Condition: Aortic Regurgitation
Intervention: Device: HAART 300 Annuloplasty Device
37 Terminated Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication
Conditions: Chronic Hepatitis C;   HIV Infections
Intervention: Drug: peg interferon plus ribavirin
38 Completed The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART
Conditions: HIV Seropositivity;   HIV Infection
Intervention: Drug: poly I-poly C12U
39 Completed Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
Condition: HIV Infections
Intervention: Biological: HIV gp120/NefTat/AS02A Vaccine
40 Unknown  Effects of a Phone Call Intervention to Promote HAART Adherence
Condition: Medication Adherence
Intervention: Behavioral: Phone call intervention, no phone call intervention

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years